Protecting women and families

Protecting women and families

Postpartum haemorrhage is the leading direct cause of maternal death worldwide. Ferring is collaborating with organisations to address this together, as we believe that no woman should die while giving birth.

Protecting women and families

At Ferring, we believe everyone going through childbirth should have access to quality care and treatment to help them build families. This is why we are working to reduce the devastating impact that postpartum haemorrhage has on women and families around the world.

Reducing maternal mortality

Every year, 14 million women suffer from PPH, or excessive bleeding after childbirth.¹ This causes 70,000 deaths a year, 90% of which are in low- and lower middle-income countries.² Most of these deaths are preventable with uterotonic medicines, which help the uterus to contract and stop the bleeding. Ferring scientists developed a uterotonic compound called carbetocin which has been approved since 1997.

To find out more about the impact of PPH globally take a look at our infographic.

Read more on what Ferring is doing to improve Safe Birth for women around the world.

Collaborating to find new ways to protect people and families

Ferring developed a heat-stable formulation of carbetocin to specifically address limitations in refrigeration and cold-chain transport of PPH medications in low- and lower-middle income countries.

Heat-stable carbetocin was researched and developed as part of the CHAMPION (*Carbetocin Haemorrhage Prevention) trial programme, the largest ever randomized study in the prevention of PPH, in collaboration with WHO and Merck for Mothers. Results of the CHAMPION trial published in the New England Journal of Medicine were announced in 2018, see here.

Ferring and key partners are working to bring access to heat-stable carbetocin in low- and lower-middle income countries, where the burden of maternal mortality is greatest.


  1. World Health Organization. Priority diseases and reasons for inclusion. Postpartum haemorrhage. Available at:  Last accessed: June 2021.
  2. Say L, et al. Global causes of maternal death: a WHO systematic analysis. The Lancet Global Health. 2014; 2(6):e323-33. Available at: Last accessed: June 2021.

©Joni Kabana Photography/Concept Foundation/Ferring Pharmaceuticals/MSD for Mothers

Learn more about Ferring’s commitment

to reducing maternal mortality

This page is not intended for patients or for members of the general public. It is only intended to be used by healthcare professionals.


Cette page n'est pas destinée aux patients ou au grand public. Il est uniquement destiné à être utilisé par des professionnels de santé.


Ik bevestig dat ik een professionele zorgverlener ben of een zakelijke relatie heb met Ferring Pharmaceuticals


Ez az oldal nem betegeknek, vagy nagyközönségnek szól. Az oldalt kizárólag egészségügyi szakemberek használhatják.


Ta strona nie jest przeznaczona dla pacjentów ani dla ogółu odwiedzających. Ta strona stworzona jest dla pracowników sektora ochrony zdrowia.


Эта страница не предназначена для пациентов или для широкой публики. Она предназначена только для медицинских работников.